Sort
8,912 grants matching “sars cov 2”
Imaging SARS-CoV-2 proteases for spatio-temporal insight into Covid-19
$433,927Jesse Vincent Jokerst · University Of California, San Diego · R21 · FY2020 · AI
A rapid CRISPR-based self-testing platform for early detection of HIV
$433,887Piyush K Jain · University Of Florida · R61 · FY2024 · AI
Defining the molecular and anatomical basis of the blood-olfactory barrier (BOB)
$433,879E. Ashley Moseman · Duke University · R21 · FY2023 · DC
Designing neutralization antibodies against Sars-Cov-2
$433,750Wei Wang · University Of California, San Diego · R21 · FY2020 · AI
Peptides and small-molecules targeting signaling proteins and protein-protein interfaces
$433,750Harish Vashisth · University Of New Hampshire · R35 · FY2025 · GM
Rolosense: An innovative platform for automatic mobile phone readout of active SARS-CoV-2 particles
$433,540Khalid S. Salaita · Emory University · U01 · FY2022 · AA
Administrative Core
$433,524John Scribner Schieffelin · Tulane University Of Louisiana · U54 · FY2022 · CA
Investigation of whether Topoisomerase 3b can be a drug target for SARS-CoV-2 and other positive-strand RNA virus; and development of such a drug
$433,381Weidong Wang · National Institute On Aging · ZIA · FY2024 · AG
Nanobody-Based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2
$433,266John R Cirrito · Washington University · U01 · FY2021 · AA
Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
$433,161David A. Zidar · Case Western Reserve University · U01 · FY2024 · CA
Group testing for infectious disease detection
$433,066Christopher R Bilder · University Of Nebraska Lincoln · R01 · FY2022 · AI
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19
$432,694Michael R Wilson · University Of California, San Francisco · R01 · FY2025 · NS
Auditory Insights into Post-Acute Sequelae of SARS-CoV-2 Infection: Unveiling Abnormal Auditory Perception and Diagnostic Markers through Complex Auditory Performance Tests.
$432,632Christopher Edward Niemczak · Dartmouth-Hitchcock Clinic · R21 · FY2025 · DC
Validation of Smart Masks for Surveillance of COVID-19
$432,457Jesse Vincent Jokerst · University Of California, San Diego · R01 · FY2022 · DE
Mechanophenotyping RBC subpopulations in ME/CFS
$432,431Anand K Ramasubramanian · San Jose State University · R15 · FY2025 · HL
Project 3: Defining the antibody landscape after SARS-CoV-2 infection
$432,172Sabra L Klein · Johns Hopkins University · U54 · FY2022 · CA
Paper-COVID - Platform for High-throughput SARS-CoV-2 Screening and Contact Tracing
$432,028David Erickson · Cornell University · R21 · FY2021 · EB
Genetic and Molecular Basis of Longevity
$431,960Gary B. Ruvkun · Massachusetts General Hospital · R01 · FY2022 · AG
Genetic and Molecular Basis of Longevity
$431,960Gary B. Ruvkun · Massachusetts General Hospital · R01 · FY2024 · AG
Genetic and Molecular Basis of Longevity
$431,960Gary B. Ruvkun · Massachusetts General Hospital · R01 · FY2023 · AG
Low-Cost Versatile Sampler for Personal PM Exposure by Microenvironment
$431,880Charles S Henry · Colorado State University · R33 · FY2020 · ES
Core 07: Clinical Research Resources Core
$431,320Judd E Shellito · Lsu Pennington Biomedical Research Ctr · U54 · FY2024 · GM
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
$431,130Edward Chu · Albert Einstein College Of Medicine · P30 · FY2022 · CA
Task C11: Using a Human Lung Microphysiologic System to Model SARS-CoV-2 Infection and Test Candidate Countermeasures
$430,965David Beasley · University Of Texas Med Br Galveston · N01 · FY2022 · AI
In vivo tracking of inhaled ACE2 targeting theranostic nanodrugs delivery to the lungs using magnetic particle imaging
$430,375Ping Wang · Michigan State University · R21 · FY2021 · AI